Last reviewed · How we verify
Imitrex Oral Product
At a glance
| Generic name | Imitrex Oral Product |
|---|---|
| Also known as | Sumatriptan |
| Sponsor | Targia Pharmaceuticals Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) (PHASE1)
- Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants (PHASE1)
- Drug and Non-Drug Treatment Of Severe Migraine (PHASE4)
- Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers (PHASE1)
- A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |